-
Views
-
Cite
Cite
M. Sans Merce, N. Ruiz, I. Barth, A. Carnicer, L. Donadille, P. Ferrari, M. Fulop, M. Ginjaume, G. Gualdrini, S. Krim, F. Mariotti, X. Ortega, A. Rimpler, F. Vanhavere, S. Baechler, Extremity exposure in nuclear medicine: preliminary results of a European study, Radiation Protection Dosimetry, Volume 144, Issue 1-4, March 2011, Pages 515–520, https://doi.org/10.1093/rpd/ncq574
- Share Icon Share
Abstract
The Work Package 4 of the ORAMED project, a collaborative project (2008–11) supported by the European Commission within its seventh Framework Programme, is concerned with the optimisation of the extremity dosimetry of medical staff in nuclear medicine. To evaluate the extremity doses and dose distributions across the hands of medical staff working in nuclear medicine departments, an extensive measurement programme has been started in 32 nuclear medicine departments in Europe. This was done using a standard protocol recording all relevant information for radiation exposure, i.e. radiation protection devices and tools. This study shows the preliminary results obtained for this measurement campaign. For diagnostic purposes, the two most-used radionuclides were considered: 99mTc and 18F. For therapeutic treatments, Zevalin® and DOTATOC (both labelled with 90Y) were chosen. Large variations of doses were observed across the hands depending on different parameters. Furthermore, this study highlights the importance of the positioning of the extremity dosemeter for a correct estimate of the maximum skin doses.